Overview

Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib

Status:
Terminated
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
We are going to use a special type of bronchoscopy test to examine patients who have had previous surgical treatment for lung cancer or head and neck cancer. The aim is to determine a) whether we can identify precancerous changes in their airways b) whether this type of testing is acceptable and c) get an initial idea of whether a new drug called gefitinib has any effect on precancerous areas in the airway.
Phase:
Phase 2
Details
Lead Sponsor:
Papworth Hospital NHS Foundation Trust
Collaborators:
AstraZeneca
Noble Organisation
Treatments:
Gefitinib